Article
A Patient-Derived Tumoroid Platform for NF1 Low-Grade Glioma shows Myeloid Evolution and Shifting Metabolic Dependencies in vitro
2026-03-25
Abstract excerpt
<title>Abstract</title> <p> About 10–15% of individuals with Neurofibromatosis Type 1 develop a low-grade glioma (LGG) within the optic pathway, and an additional 3–5% of individuals develop LGG outside of the optic pathway. In recent years molecular analysis has greatly enhanced our understanding of what drives these NF1 LGG; however, to date <italic>in vitro</italic> and <italic>in vivo</italic> models are...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 35fb2871-ace9-52be-a172-c85d1593804a
- DOI
- 10.21203/rs.3.rs-9118779/v1
